<DOC>
	<DOCNO>NCT01158547</DOCNO>
	<brief_summary>The purpose study assess ability CLR3001 reverse depressive symptom relatively quickly adult patient major depressive disorder ( MDD ) .</brief_summary>
	<brief_title>Efficacy Study CLR3001 Depression</brief_title>
	<detailed_description>CLR3001 think work help body 's natural response overcome depression .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>Male female outsubjects 1865 year . Single episode recurrent MDD ( maximum 5 prior episode ) . No current therapy depression per washout instruction . Able provide write informed consent . Meet criterion MDD current MDE MINI questionnaire . Meet criterion MDD current MDE , define DSMIV TR . HAMD17 score ≥ 14 screening ( visit 1 ) baseline ( Visit 2 ; Randomization ) . Able understand complete questionnaire , communicate investigator study coordinator . Judged reliable keep appointment procedure require protocol . Female subject childbearing potential ( least 2 year postmenopausal surgically sterile totally abstinent ) must use reliable , medically acceptable form contraception must agree continue use throughout duration study . Reliable form contraception include oral , implanted , transdermal injected contraceptive , intrauterine device , adequate double barrier method include use spermicide . Partner 's vasectomy also acceptable contraceptive regimen . Investigators immediate family member . Treatment within last 90 day drug receive regulatory approval time study entry . Persons previously withdraw study previous study investigate CLR3001 . A primary diagnosis Panic Disorder , Social Anxiety Disorder , ObsessiveCompulsive Disorder within past year . The presence Axis II disorder , , opinion investigator , would interfere compliance study . History active substance dependence within last halfyear , exclude nicotine coffee , active substance abuse may interfere outcome study . Acute suicidal ideation risk , ≥3 HAMD17 suicide item . Fall HAMD17 score great 20 % Visit 1 Visit 2 . Serious concomitant disease cancer , serious metabolic ( e.g . Insulin dependent diabetes ) , renal , cardiac , thyroid , immunological , neurological significant disease laboratory abnormality ( hematology , blood chemistry , ECG ) , treatment medical condition may interact CLR3001 . Women pregnant breastfeeding , men woman plan Infirmities live area limit participation study compliance study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>